Studying Umbilical Cord Blood From African-American Donors
NCT ID: NCT00717535
Last Updated: 2013-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2005-08-31
2009-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This clinical trial is looking at umbilical cord blood from African-American donors.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Collection and Storage of Umbilical Cord Blood for Transplantation
NCT01728545
Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation
NCT00737516
Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic Disorders
NCT00897260
Expanded Cord Blood in Patients in Need of an Allogeneic Stem Cell Transplant
NCT02668315
Umbilical Cord Blood Stem Cell Transplantation in Adults With Advanced Blood Disorders or Cancer
NCT00312429
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* To correlate the total nucleated cell yield of cord blood units from African-American cord blood donors with gestational history, maternal history, and delivery information.
OUTLINE: This is a multicenter study.
Donors complete questionnaires about their demographics, maternal history, gestational history, and delivery. Cord blood units (CBU) are collected in utero and transported to the Stem Cell Processing Laboratory where they are evaluated for CBU volume and cell count (i.e., total nucleated cell yield) and cryopreserved. The study results will then be used to devise future interventional strategies to improve the yield of nucleated cells of CBU.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cryopreservation
questionnaire administration
study of socioeconomic and demographic variables
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* African-American participant in the National Marrow Donor Program cord blood collection protocol C-2844
* Recruited from the Labor and Delivery Suites of the Detroit Medical Center or its affiliated sites
PATIENT CHARACTERISTICS:
* Not specified
PRIOR CONCURRENT THERAPY:
* Not specified
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Barbara Ann Karmanos Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Voravit Ratanatharathorn, MD
Role: PRINCIPAL_INVESTIGATOR
Barbara Ann Karmanos Cancer Institute
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WSU-C-2933
Identifier Type: -
Identifier Source: secondary_id
WSU-W81XWH-05-1-0266
Identifier Type: -
Identifier Source: secondary_id
WSU-024405MP4E
Identifier Type: OTHER
Identifier Source: secondary_id
WSU-0505001823
Identifier Type: OTHER
Identifier Source: secondary_id
CDR0000598111
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.